NHL (non-Hodgkin lymphoma)

Clinical trials for NHL (non-Hodgkin lymphoma) explained in plain language.

Never miss a new study

Get alerted when new NHL (non-Hodgkin lymphoma) trials appear

Sign up with your email to follow new studies for NHL (non-Hodgkin lymphoma), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New injection shows promise for Hard-to-Treat cancers

Disease control Recruiting now

This early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of lymphoma that has come back or not responded to treatment. The main goal is to find a safe dose and check for side effects. About 14 participants will receive the drug as a sh…

Matched conditions: NHL (NON-HODGKIN LYMPHOMA)

Phase 1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

NHL (non-Hodgkin lymphoma)

Get alerted when new NHL (non-Hodgkin lymphoma) trials appear

New injection shows promise for Hard-to-Treat cancers